Adynxx, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-01: Study NCT04104919; Company role Lead sponsor; Phase Phase 2; Status Withdrawn.
- 2021-01: Study NCT03797612; Company role Lead sponsor; Phase Phase 2; Status Withdrawn.
- 2017-02-20: Study NCT02807428; Company role Lead sponsor; Phase Phase 2; Status Completed.
- 2015-06: Study NCT02506452; Company role Lead sponsor; Phase Not applicable; Status Unknown.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-01 | NCT04104919 Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores | Lead sponsor | Phase 2 | Withdrawn | Pain, Postoperative | 0 | 2022-02 |
| 2021-01 | NCT03797612 Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores | Lead sponsor | Phase 2 | Withdrawn | Pain, Postoperative | 0 | 2022-02 |
| 2017-02-20 | NCT02807428 Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery | Lead sponsor | Phase 2 | Completed | Post-surgical Pain | 210 | 2017-12-19 |
| 2015-06 | NCT02506452 Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers | Lead sponsor | Not applicable | Unknown | Diabetic Foot Ulcers | 51 | 2017-12 |
| 2014-05 | NCT02081703 Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery | Lead sponsor | Phase 2 | Completed | Postsurgical Pain | 120 | 2015-06 |
| 2013-01 | NCT01731730 Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery | Lead sponsor | Phase 2 | Completed | Postsurgical Pain | 102 | 2013-11 |